As vaccinations continue to ramp up, so, too, should the general public’s buy-in on the vaccine, specifically those who may be eligible but remain reluctant, said Mary Hayney, professor of pharmacy at UW-Madison’s School of Pharmacy.
As vaccinations continue to ramp up, so, too, should the general public’s buy-in on the vaccine, specifically those who may be eligible but remain reluctant, said Mary Hayney, professor of pharmacy at UW-Madison’s School of Pharmacy.